Cargando…
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation
Cancer cells reprogram cellular metabolism to meet the demands of growth. Identification of the regulatory machinery that regulates cancer-specific metabolic changes may open new avenues for anti-cancer therapeutics. The epigenetic regulator BRG1 is a catalytic ATPase for some mammalian SWI/SNF chro...
Autores principales: | Wu, Qiong, Madany, Pasil, Dobson, Jason R., Schnabl, Jake M., Sharma, Soni, Smith, Tara C., van Wijnen, Andre J., Stein, Janet L., Lian, Jane B., Stein, Gary S., Muthuswami, Rohini, Imbalzano, Anthony N., Nickerson, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122388/ https://www.ncbi.nlm.nih.gov/pubmed/27223259 http://dx.doi.org/10.18632/oncotarget.9505 |
Ejemplares similares
-
The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a
driver of cancer
por: Wu, Qiong, et al.
Publicado: (2017) -
Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells
por: Wu, Qiong, et al.
Publicado: (2016) -
BRG1, a SWI/SNF chromatin remodeling enzyme ATPase, is required for maintenance of nuclear shape and integrity
por: Imbalzano, Anthony N., et al.
Publicado: (2013) -
The connection between BRG1, CTCF and topoisomerases at TAD boundaries
por: Barutcu, A. Rasim, et al.
Publicado: (2017) -
BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer
por: Muthuswami, Rohini, et al.
Publicado: (2019)